Back | Next |
home / stock / ions / ions message board
Subject | By | Source | When |
---|---|---|---|
Headed to 57 I feel it in my bones! | Ocotillio | investorshub | 11/07/2018 8:27:03 PM |
Ready to Rocket! | Ocotillio | investorshub | 10/31/2018 3:24:02 PM |
Jimmy: The FDA is seriously underfunded and being pulled | shub | investorshub | 09/19/2018 6:10:02 PM |
The advisory committee recommended approval. A very small | jimmy667 | investorshub | 08/28/2018 1:54:56 AM |
drbio45 | investorshub | 06/17/2018 2:41:08 PM | |
So our new drug that gives a | shub | investorshub | 10/24/2017 7:05:30 PM |
Ionis Pharmaceuticals, Inc. (NASDAQ:$IONS): Stochastic Analysis | HERMES8 | investorshub | 10/13/2017 7:32:42 PM |
So, let's see.... | shub | investorshub | 10/13/2017 6:09:55 PM |
Thanks Capecod. | shub | investorshub | 09/19/2017 6:58:14 PM |
If you want to be on a large | Capecod1 | investorshub | 09/19/2017 1:00:16 AM |
That would explain the paucity of postings. | shub | investorshub | 09/18/2017 5:55:34 PM |
Is there a private board on this platform | Capecod1 | investorshub | 09/16/2017 5:57:36 PM |
And between us we darn near own this board..grin. | shub | investorshub | 08/08/2017 7:37:37 PM |
I like this company too. | Thoro | investorshub | 08/08/2017 6:36:36 PM |
Thanks for the updates Thoro; | shub | investorshub | 08/08/2017 6:16:08 PM |
IONS, $AKCA, Akcea and Ionis Announce Submission of | Thoro | investorshub | 07/27/2017 2:39:29 PM |
Anyone think this will be over $70 by | Thoro | investorshub | 07/25/2017 9:02:26 PM |
Ionis Pharmaceuticals reports phase 1/2 clinical study results | Thoro | investorshub | 07/17/2017 5:14:06 PM |
Ionis Pharmaceuticals presents new data at peripheral nerve | Thoro | investorshub | 07/17/2017 5:11:10 PM |
Ionis receives $10 mln milestone payment from Biogen | Thoro | investorshub | 07/17/2017 5:09:35 PM |
News, Short Squeeze, Breakout and More Instantly...
Ionis Pharmaceuticals Inc. Company Name:
IONS Stock Symbol:
NASDAQ Market:
Ionis Pharmaceuticals Inc. Website:
Ionis to hold first quarter 2024 financial results webcast PR Newswire Webcast scheduled for Tuesday, May 7 at 11:30 a.m. Eastern Time CARLSBAD, Calif. , April 23, 2024 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced toda...
2024-04-12 13:22:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-04-09 18:30:03 ET Wolfe Research analyst issues OUTPERFORM recommendation for IONS on April 9, 2024 04:39PM ET. IONS was trading at $42.83 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst recommendations are : 6 - Buy, 3 -...